Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Understanding the dynamics of thrombin in cardiovascular disease: pathobiology and biochemistry for the clinician.

× No keyword cloud information.

6 in total

1. Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.

Authors: Karl-Heinz Liesenfeld; Hans G Schäfer; Iñaki F Trocóniz; Christiane Tillmann; Bengt I Eriksson; Joachim Stangier
Journal: Br J Clin Pharmacol Date: 2006-11 Impact factor: 4.335

2. Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.

Authors: Joachim Stangier; Hildegard Stähle; Karin Rathgen; Reinhold Fuhr
Journal: Clin Pharmacokinet Date: 2008 Impact factor: 6.447

3. The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.

Authors: Binita Shah; Jeffrey S Berger; Nicole Allen; Yu Guo; Steven P Sedlis; Jinfeng Xu; Adriana Perez; Michael Attubato; James Slater; Frederick Feit
Journal: Catheter Cardiovasc Interv Date: 2016-01-16 Impact factor: 2.692

Understanding the dynamics of thrombin in cardiovascular disease: pathobiology and biochemistry for the clinician.

1. Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.

2. Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.

3. The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.

Review 4. Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review.

Review 5. Bivalirudin in percutaneous coronary intervention.

Review 6. Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond.